| http://www.w3.org/ns/prov#value | - Agent: Protan Bio Co., Ltd.20120252041 - Method of prognosis: The present invention relates to the use of soluble CD163 as a prognostic marker for the assessment of the risk for contracting a disorder, in particular for contracting diabetes and/or a liver disorder.
|
